

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin filament depolymerization (GO:0030042) | 6.18558277 |
| 2 | bile acid and bile salt transport (GO:0015721) | 6.17876972 |
| 3 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 6.10799079 |
| 4 | flavonoid metabolic process (GO:0009812) | 6.06336520 |
| 5 | intestinal absorption (GO:0050892) | 6.03634063 |
| 6 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.88052089 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 5.33433752 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.27849453 |
| 9 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.17415915 |
| 10 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.17415915 |
| 11 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 5.16869005 |
| 12 | regulation of bile acid biosynthetic process (GO:0070857) | 5.07066362 |
| 13 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 5.04743449 |
| 14 | NADH metabolic process (GO:0006734) | 4.87260090 |
| 15 | epithelial structure maintenance (GO:0010669) | 4.82823209 |
| 16 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.79476551 |
| 17 | lipoprotein transport (GO:0042953) | 4.65308796 |
| 18 | regulation of cellular extravasation (GO:0002691) | 4.63900342 |
| 19 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.54528905 |
| 20 | cellular response to virus (GO:0098586) | 4.53703925 |
| 21 | angiotensin maturation (GO:0002003) | 4.44222410 |
| 22 | peptide hormone processing (GO:0016486) | 4.42881977 |
| 23 | sulfate transmembrane transport (GO:1902358) | 4.40231644 |
| 24 | fructose metabolic process (GO:0006000) | 4.38645237 |
| 25 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.37392618 |
| 26 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.37392618 |
| 27 | endocrine process (GO:0050886) | 4.37392618 |
| 28 | cGMP-mediated signaling (GO:0019934) | 4.27580876 |
| 29 | vitamin transmembrane transport (GO:0035461) | 4.21131073 |
| 30 | uterus development (GO:0060065) | 4.17690581 |
| 31 | transcytosis (GO:0045056) | 4.16723018 |
| 32 | drug metabolic process (GO:0017144) | 4.14161989 |
| 33 | intestinal cholesterol absorption (GO:0030299) | 4.13548719 |
| 34 | phosphatidylcholine biosynthetic process (GO:0006656) | 4.10927261 |
| 35 | desmosome organization (GO:0002934) | 4.10185940 |
| 36 | antibacterial humoral response (GO:0019731) | 4.08349404 |
| 37 | positive regulation of respiratory burst (GO:0060267) | 4.07568178 |
| 38 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.04391199 |
| 39 | diacylglycerol metabolic process (GO:0046339) | 4.02335474 |
| 40 | sulfation (GO:0051923) | 4.00815096 |
| 41 | cellular glucuronidation (GO:0052695) | 3.99766714 |
| 42 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.97396065 |
| 43 | antimicrobial humoral response (GO:0019730) | 3.92698433 |
| 44 | regulation of systemic arterial blood pressure (GO:0003073) | 3.89386508 |
| 45 | regulation of guanylate cyclase activity (GO:0031282) | 3.86115398 |
| 46 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.83836024 |
| 47 | cobalamin metabolic process (GO:0009235) | 3.82007719 |
| 48 | bicarbonate transport (GO:0015701) | 3.77086586 |
| 49 | hormone catabolic process (GO:0042447) | 3.76416903 |
| 50 | sulfur amino acid catabolic process (GO:0000098) | 3.71972393 |
| 51 | digestive system process (GO:0022600) | 3.71672924 |
| 52 | response to hepatocyte growth factor (GO:0035728) | 3.69831933 |
| 53 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.69831933 |
| 54 | peptide catabolic process (GO:0043171) | 3.67580127 |
| 55 | transepithelial transport (GO:0070633) | 3.64610478 |
| 56 | plasma lipoprotein particle assembly (GO:0034377) | 3.56793938 |
| 57 | auditory receptor cell differentiation (GO:0042491) | 3.54681401 |
| 58 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.52608289 |
| 59 | regulation of actin nucleation (GO:0051125) | 3.52247852 |
| 60 | macroautophagy (GO:0016236) | 3.52159268 |
| 61 | sulfate transport (GO:0008272) | 3.49622845 |
| 62 | positive regulation of pseudopodium assembly (GO:0031274) | 3.48472386 |
| 63 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.47800503 |
| 64 | thrombin receptor signaling pathway (GO:0070493) | 3.47054947 |
| 65 | arginine metabolic process (GO:0006525) | 3.46262983 |
| 66 | response to pheromone (GO:0019236) | 3.43653192 |
| 67 | uronic acid metabolic process (GO:0006063) | 3.43520094 |
| 68 | glucuronate metabolic process (GO:0019585) | 3.43520094 |
| 69 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.40835759 |
| 70 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.38584820 |
| 71 | neurotransmitter biosynthetic process (GO:0042136) | 3.35738965 |
| 72 | sulfur compound transport (GO:0072348) | 3.35585174 |
| 73 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.34452432 |
| 74 | fucose catabolic process (GO:0019317) | 3.34238114 |
| 75 | L-fucose metabolic process (GO:0042354) | 3.34238114 |
| 76 | L-fucose catabolic process (GO:0042355) | 3.34238114 |
| 77 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.33737054 |
| 78 | macrophage chemotaxis (GO:0048246) | 3.33174363 |
| 79 | positive regulation of interferon-alpha production (GO:0032727) | 3.30725545 |
| 80 | vitamin A metabolic process (GO:0006776) | 3.30641120 |
| 81 | regulation of cholesterol esterification (GO:0010872) | 3.28845132 |
| 82 | ethanol oxidation (GO:0006069) | 3.26361022 |
| 83 | glucose 6-phosphate metabolic process (GO:0051156) | 3.26104168 |
| 84 | regulation of viral release from host cell (GO:1902186) | 3.25110635 |
| 85 | vitamin transport (GO:0051180) | 3.24921181 |
| 86 | L-ascorbic acid metabolic process (GO:0019852) | 3.24049173 |
| 87 | glycolipid catabolic process (GO:0019377) | 3.23994605 |
| 88 | intestinal epithelial cell development (GO:0060576) | 3.22960066 |
| 89 | phospholipid efflux (GO:0033700) | 3.21523494 |
| 90 | low-density lipoprotein particle remodeling (GO:0034374) | 3.18652460 |
| 91 | negative regulation of sterol transport (GO:0032372) | 3.18545634 |
| 92 | negative regulation of cholesterol transport (GO:0032375) | 3.18545634 |
| 93 | high-density lipoprotein particle remodeling (GO:0034375) | 3.18516855 |
| 94 | lipoprotein metabolic process (GO:0042157) | 3.17987355 |
| 95 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.17968598 |
| 96 | sphingomyelin metabolic process (GO:0006684) | 3.16785643 |
| 97 | low-density lipoprotein particle clearance (GO:0034383) | 3.16615354 |
| 98 | exogenous drug catabolic process (GO:0042738) | 3.16524869 |
| 99 | regulation of cGMP metabolic process (GO:0030823) | 3.15609532 |
| 100 | protein targeting to Golgi (GO:0000042) | 3.15310404 |
| 101 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.13304750 |
| 102 | nucleotide transmembrane transport (GO:1901679) | 3.13073092 |
| 103 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.12776481 |
| 104 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.12650728 |
| 105 | regulation of protein glycosylation (GO:0060049) | 3.12419601 |
| 106 | regulation of pseudopodium assembly (GO:0031272) | 3.11275425 |
| 107 | plasma lipoprotein particle remodeling (GO:0034369) | 3.09846085 |
| 108 | protein-lipid complex remodeling (GO:0034368) | 3.09846085 |
| 109 | macromolecular complex remodeling (GO:0034367) | 3.09846085 |
| 110 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.09824322 |
| 111 | digestion (GO:0007586) | 3.08912375 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.08291399 |
| 113 | drug catabolic process (GO:0042737) | 3.08097871 |
| 114 | regulation of interferon-alpha production (GO:0032647) | 3.07978401 |
| 115 | bile acid metabolic process (GO:0008206) | 3.07213748 |
| 116 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.05240539 |
| 117 | eosinophil chemotaxis (GO:0048245) | 3.04887595 |
| 118 | vitamin biosynthetic process (GO:0009110) | 3.03576935 |
| 119 | renal system process involved in regulation of blood volume (GO:0001977) | 3.03394925 |
| 120 | urea cycle (GO:0000050) | 2.99004468 |
| 121 | primary alcohol catabolic process (GO:0034310) | 2.98534807 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 2.98135314 |
| 123 | glutathione biosynthetic process (GO:0006750) | 2.96768283 |
| 124 | O-glycan processing (GO:0016266) | 2.95123566 |
| 125 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.94007919 |
| 126 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.94007919 |
| 127 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.94007919 |
| 128 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.93058375 |
| 129 | reverse cholesterol transport (GO:0043691) | 2.90320509 |
| 130 | response to hydroperoxide (GO:0033194) | 2.89593878 |
| 131 | drug transport (GO:0015893) | 2.89343912 |
| 132 | plasma lipoprotein particle organization (GO:0071827) | 2.89116460 |
| 133 | cellular anion homeostasis (GO:0030002) | 2.88835843 |
| 134 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.86630221 |
| 135 | complement activation, classical pathway (GO:0006958) | 2.86098129 |
| 136 | cholesterol homeostasis (GO:0042632) | 2.85887052 |
| 137 | urea metabolic process (GO:0019627) | 2.85760115 |
| 138 | negative regulation of defense response to virus (GO:0050687) | 2.84482255 |
| 139 | regulation of vitamin metabolic process (GO:0030656) | 2.84464494 |
| 140 | regulation of viral entry into host cell (GO:0046596) | 2.84294816 |
| 141 | cytokine biosynthetic process (GO:0042089) | 2.83916822 |
| 142 | epithelial cell-cell adhesion (GO:0090136) | 2.83653643 |
| 143 | virion attachment to host cell (GO:0019062) | 2.83105318 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.83105318 |
| 145 | fat-soluble vitamin metabolic process (GO:0006775) | 2.82875718 |
| 146 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.82697767 |
| 147 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.82582123 |
| 148 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.82369202 |
| 149 | phosphatidylcholine metabolic process (GO:0046470) | 2.80162807 |
| 150 | membrane lipid catabolic process (GO:0046466) | 2.80035481 |
| 151 | sterol homeostasis (GO:0055092) | 2.79635060 |
| 152 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.78245340 |
| 153 | sperm capacitation (GO:0048240) | 2.77545020 |
| 154 | chondrocyte proliferation (GO:0035988) | 2.76958754 |
| 155 | ceramide catabolic process (GO:0046514) | 2.76795942 |
| 156 | purine ribonucleotide transport (GO:0015868) | 2.75901912 |
| 157 | filopodium assembly (GO:0046847) | 2.74920246 |
| 158 | oligosaccharide biosynthetic process (GO:0009312) | 2.74748412 |
| 159 | thyroid hormone metabolic process (GO:0042403) | 2.74204287 |
| 160 | leukocyte apoptotic process (GO:0071887) | 2.69842555 |
| 161 | regulation of triglyceride catabolic process (GO:0010896) | 2.68318946 |
| 162 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.67190376 |
| 163 | regulation of cGMP biosynthetic process (GO:0030826) | 2.66515574 |
| 164 | ethanol metabolic process (GO:0006067) | 2.66487148 |
| 165 | alkaloid metabolic process (GO:0009820) | 2.66337681 |
| 166 | galactose catabolic process (GO:0019388) | 2.65415639 |
| 167 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.65326962 |
| 168 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.65224173 |
| 169 | establishment of protein localization to Golgi (GO:0072600) | 2.64533652 |
| 170 | regulation of proton transport (GO:0010155) | 2.64337466 |
| 171 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.64311623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.84441605 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.07278093 |
| 3 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 3.99255297 |
| 4 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.64290002 |
| 5 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.21422577 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.03015216 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.97447414 |
| 8 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.94253411 |
| 9 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.57308281 |
| 10 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.50371020 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.48069957 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.45072313 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.29257062 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.19292042 |
| 15 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.17336769 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09330859 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.05736219 |
| 18 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.03462378 |
| 19 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.02245911 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.97250594 |
| 21 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.92977111 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88091354 |
| 23 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.81332072 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80535638 |
| 25 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.79443687 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75280967 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.74359520 |
| 28 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.72846303 |
| 29 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.68637540 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65925455 |
| 31 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.64180004 |
| 32 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.58799405 |
| 33 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.53955738 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.52713349 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50283863 |
| 36 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.49318185 |
| 37 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.45499722 |
| 38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43048930 |
| 39 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41877012 |
| 40 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.39634199 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39007703 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37195912 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35628691 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.31809894 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29627569 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28135911 |
| 47 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.26196312 |
| 48 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24746354 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24656910 |
| 50 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24326684 |
| 51 | AR_20517297_ChIP-Seq_VCAP_Human | 1.20603746 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19674027 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.19623758 |
| 54 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16805633 |
| 55 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16805633 |
| 56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16117753 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15972638 |
| 58 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.14859715 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.14024720 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12591349 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.12519067 |
| 62 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.11830740 |
| 63 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11452663 |
| 64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10418639 |
| 65 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09676430 |
| 66 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.09588320 |
| 67 | VDR_22108803_ChIP-Seq_LS180_Human | 1.09070695 |
| 68 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.08417059 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06106942 |
| 70 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.03487891 |
| 71 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.02441178 |
| 72 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02104930 |
| 73 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.01494093 |
| 74 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00277181 |
| 75 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99271675 |
| 76 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.99063197 |
| 77 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98848951 |
| 78 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98601675 |
| 79 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.98269260 |
| 80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97255350 |
| 81 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.95979987 |
| 82 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94388330 |
| 83 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.94141379 |
| 84 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92902218 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92777062 |
| 86 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.91837938 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91740498 |
| 88 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.91696479 |
| 89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91482509 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91350667 |
| 91 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90947878 |
| 92 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90773492 |
| 93 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.90500368 |
| 94 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.90265126 |
| 95 | NCOR_22424771_ChIP-Seq_293T_Human | 0.89875667 |
| 96 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.89211477 |
| 97 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.89161716 |
| 98 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.89016435 |
| 99 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.88875333 |
| 100 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.88845430 |
| 101 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.88165355 |
| 102 | NFYA_21822215_ChIP-Seq_K562_Human | 0.88041467 |
| 103 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87951339 |
| 104 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.87762560 |
| 105 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.86901290 |
| 106 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86329497 |
| 107 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.86197987 |
| 108 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85921377 |
| 109 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85921377 |
| 110 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85258557 |
| 111 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.84977590 |
| 112 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.84885554 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84759290 |
| 114 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.84599317 |
| 115 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.84334568 |
| 116 | * STAT1_20625510_ChIP-Seq_HELA_Human | 0.84092205 |
| 117 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.84028534 |
| 118 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82918962 |
| 119 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82879753 |
| 120 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.82463418 |
| 121 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.82463418 |
| 122 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.81907491 |
| 123 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.81863003 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81845415 |
| 125 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81356968 |
| 126 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.80298905 |
| 127 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.79957561 |
| 128 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.79091681 |
| 129 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.78936188 |
| 130 | SA1_27219007_Chip-Seq_Bcells_Human | 0.78903458 |
| 131 | CBP_21632823_ChIP-Seq_H3396_Human | 0.78693449 |
| 132 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.78429963 |
| 133 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.78289284 |
| 134 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77815156 |
| 135 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77436711 |
| 136 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77195770 |
| 137 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.76887308 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76307631 |
| 139 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.75568966 |
| 140 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75566942 |
| 141 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74621007 |
| 142 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.74130847 |
| 143 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.73996514 |
| 144 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.73302390 |
| 145 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.72080215 |
| 146 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.71004811 |
| 147 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.70746069 |
| 148 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.70533915 |
| 149 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.70437339 |
| 150 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.70009192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 7.66095299 |
| 2 | MP0002822_catalepsy | 5.86507689 |
| 3 | MP0003283_abnormal_digestive_organ | 4.38863526 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 4.35129270 |
| 5 | MP0003878_abnormal_ear_physiology | 4.35129270 |
| 6 | MP0005360_urolithiasis | 3.67150136 |
| 7 | MP0001666_abnormal_nutrient_absorption | 3.46433449 |
| 8 | MP0003315_abnormal_perineum_morphology | 3.37035256 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.30183762 |
| 10 | MP0000462_abnormal_digestive_system | 3.12332171 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 3.02671081 |
| 12 | MP0008004_abnormal_stomach_pH | 2.75225493 |
| 13 | MP0005167_abnormal_blood-brain_barrier | 2.74751560 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.72593773 |
| 15 | MP0001873_stomach_inflammation | 2.66233113 |
| 16 | MP0003866_abnormal_defecation | 2.57805868 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 2.22879915 |
| 18 | MP0005332_abnormal_amino_acid | 2.19606913 |
| 19 | MP0005381_digestive/alimentary_phenotyp | 2.17471261 |
| 20 | MP0001663_abnormal_digestive_system | 2.09307135 |
| 21 | MP0001664_abnormal_digestion | 2.05630142 |
| 22 | MP0001849_ear_inflammation | 2.03294994 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.03136286 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 2.01533168 |
| 25 | MP0009379_abnormal_foot_pigmentation | 2.01000863 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.96651403 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.93692803 |
| 28 | MP0002796_impaired_skin_barrier | 1.93067745 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.91948746 |
| 30 | MP0004947_skin_inflammation | 1.80073191 |
| 31 | MP0001756_abnormal_urination | 1.72307172 |
| 32 | MP0004858_abnormal_nervous_system | 1.64897998 |
| 33 | MP0000477_abnormal_intestine_morphology | 1.64572241 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.59183336 |
| 35 | MP0000490_abnormal_crypts_of | 1.57346696 |
| 36 | MP0003195_calcinosis | 1.55740843 |
| 37 | MP0003252_abnormal_bile_duct | 1.47533830 |
| 38 | MP0000538_abnormal_urinary_bladder | 1.47470204 |
| 39 | MP0000579_abnormal_nail_morphology | 1.45646832 |
| 40 | MP0001764_abnormal_homeostasis | 1.45508640 |
| 41 | MP0009785_altered_susceptibility_to | 1.45437583 |
| 42 | MP0003941_abnormal_skin_development | 1.42773643 |
| 43 | MP0000470_abnormal_stomach_morphology | 1.41912154 |
| 44 | MP0001765_abnormal_ion_homeostasis | 1.36449011 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.33231552 |
| 46 | MP0005448_abnormal_energy_balance | 1.32782911 |
| 47 | MP0004043_abnormal_pH_regulation | 1.28516218 |
| 48 | MP0004270_analgesia | 1.25654931 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.24991072 |
| 50 | MP0010678_abnormal_skin_adnexa | 1.23714367 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.21396279 |
| 52 | MP0003718_maternal_effect | 1.21270601 |
| 53 | MP0005310_abnormal_salivary_gland | 1.18982363 |
| 54 | MP0003303_peritoneal_inflammation | 1.14366641 |
| 55 | MP0003385_abnormal_body_wall | 1.14352153 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.12272867 |
| 57 | MP0010329_abnormal_lipoprotein_level | 1.11418543 |
| 58 | MP0000372_irregular_coat_pigmentation | 1.11028539 |
| 59 | MP0003705_abnormal_hypodermis_morpholog | 1.09147700 |
| 60 | MP0002163_abnormal_gland_morphology | 1.07562483 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.07536014 |
| 62 | MP0008872_abnormal_physiological_respon | 1.04539074 |
| 63 | MP0009278_abnormal_bone_marrow | 1.03452224 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.03084130 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 1.01934307 |
| 66 | MP0005409_darkened_coat_color | 1.01281147 |
| 67 | MP0005379_endocrine/exocrine_gland_phen | 0.99773328 |
| 68 | MP0000230_abnormal_systemic_arterial | 0.99463483 |
| 69 | MP0005025_abnormal_response_to | 0.97971201 |
| 70 | MP0005501_abnormal_skin_physiology | 0.96211202 |
| 71 | MP0000013_abnormal_adipose_tissue | 0.93634148 |
| 72 | MP0002693_abnormal_pancreas_physiology | 0.92804177 |
| 73 | MP0003724_increased_susceptibility_to | 0.91220943 |
| 74 | MP0005410_abnormal_fertilization | 0.90133544 |
| 75 | MP0001485_abnormal_pinna_reflex | 0.89562112 |
| 76 | MP0005535_abnormal_body_temperature | 0.88882247 |
| 77 | MP0003953_abnormal_hormone_level | 0.88872311 |
| 78 | MP0001216_abnormal_epidermal_layer | 0.85648761 |
| 79 | MP0005365_abnormal_bile_salt | 0.85593944 |
| 80 | MP0002148_abnormal_hypersensitivity_rea | 0.85105286 |
| 81 | MP0002160_abnormal_reproductive_system | 0.83532313 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.82611345 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 0.82109401 |
| 84 | MP0005670_abnormal_white_adipose | 0.79761434 |
| 85 | MP0005166_decreased_susceptibility_to | 0.77905420 |
| 86 | MP0004147_increased_porphyrin_level | 0.76476881 |
| 87 | MP0003300_gastrointestinal_ulcer | 0.76054137 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.76015163 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.74392524 |
| 90 | MP0009840_abnormal_foam_cell | 0.72843342 |
| 91 | MP0002971_abnormal_brown_adipose | 0.72841449 |
| 92 | MP0000516_abnormal_urinary_system | 0.71569044 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 0.71569044 |
| 94 | MP0005000_abnormal_immune_tolerance | 0.70724670 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 0.70060865 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.69850169 |
| 97 | MP0001501_abnormal_sleep_pattern | 0.69371211 |
| 98 | MP0001188_hyperpigmentation | 0.68952941 |
| 99 | MP0000609_abnormal_liver_physiology | 0.68558893 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.68279732 |
| 101 | MP0002098_abnormal_vibrissa_morphology | 0.66534536 |
| 102 | MP0001944_abnormal_pancreas_morphology | 0.65950624 |
| 103 | MP0004185_abnormal_adipocyte_glucose | 0.65867820 |
| 104 | MP0003868_abnormal_feces_composition | 0.63991291 |
| 105 | MP0003879_abnormal_hair_cell | 0.63942364 |
| 106 | MP0004782_abnormal_surfactant_physiolog | 0.62630840 |
| 107 | MP0003045_fibrosis | 0.60878789 |
| 108 | MP0003436_decreased_susceptibility_to | 0.60160438 |
| 109 | MP0005395_other_phenotype | 0.60121158 |
| 110 | MP0008775_abnormal_heart_ventricle | 0.59924011 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.59661111 |
| 112 | MP0008873_increased_physiological_sensi | 0.59047357 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.57139745 |
| 114 | MP0000566_synostosis | 0.56437778 |
| 115 | MP0002060_abnormal_skin_morphology | 0.56216020 |
| 116 | MP0005220_abnormal_exocrine_pancreas | 0.55693304 |
| 117 | MP0006082_CNS_inflammation | 0.55065965 |
| 118 | MP0009115_abnormal_fat_cell | 0.53588437 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.53513360 |
| 120 | MP0001727_abnormal_embryo_implantation | 0.53293997 |
| 121 | MP0000537_abnormal_urethra_morphology | 0.52778770 |
| 122 | MP0002419_abnormal_innate_immunity | 0.52761303 |
| 123 | MP0000685_abnormal_immune_system | 0.52634298 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.51910594 |
| 125 | MP0000678_abnormal_parathyroid_gland | 0.51613475 |
| 126 | MP0002837_dystrophic_cardiac_calcinosis | 0.51270053 |
| 127 | MP0001533_abnormal_skeleton_physiology | 0.49552150 |
| 128 | MP0000467_abnormal_esophagus_morphology | 0.49130285 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.48959354 |
| 130 | MP0010386_abnormal_urinary_bladder | 0.48766984 |
| 131 | MP0008469_abnormal_protein_level | 0.47522767 |
| 132 | MP0002896_abnormal_bone_mineralization | 0.47190523 |
| 133 | MP0002006_tumorigenesis | 0.45324083 |
| 134 | MP0009642_abnormal_blood_homeostasis | 0.44693948 |
| 135 | MP0003075_altered_response_to | 0.42436664 |
| 136 | MP0002452_abnormal_antigen_presenting | 0.41738738 |
| 137 | MP0002876_abnormal_thyroid_physiology | 0.41525313 |
| 138 | MP0005387_immune_system_phenotype | 0.39567215 |
| 139 | MP0001790_abnormal_immune_system | 0.39567215 |
| 140 | MP0002234_abnormal_pharynx_morphology | 0.37811451 |
| 141 | MP0005023_abnormal_wound_healing | 0.36518875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cupped ribs (HP:0000887) | 6.74128954 |
| 2 | Hydroxyprolinuria (HP:0003080) | 5.64355096 |
| 3 | Abnormality of proline metabolism (HP:0010907) | 5.64355096 |
| 4 | Abnormality of vitamin B metabolism (HP:0004340) | 4.89680467 |
| 5 | Septate vagina (HP:0001153) | 4.70786161 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.69051177 |
| 7 | Right ventricular cardiomyopathy (HP:0011663) | 4.60617449 |
| 8 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 4.58028630 |
| 9 | Ileus (HP:0002595) | 4.21924960 |
| 10 | Abnormal tarsal ossification (HP:0008369) | 4.16514027 |
| 11 | Polycythemia (HP:0001901) | 4.04029860 |
| 12 | Flat acetabular roof (HP:0003180) | 4.03709056 |
| 13 | Abnormality of vitamin metabolism (HP:0100508) | 4.01609208 |
| 14 | Abnormality of the 1st metacarpal (HP:0010009) | 4.00373413 |
| 15 | Glycosuria (HP:0003076) | 3.95286944 |
| 16 | Abnormality of urine glucose concentration (HP:0011016) | 3.95286944 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.87435707 |
| 18 | Optic neuritis (HP:0100653) | 3.87435707 |
| 19 | Decreased circulating renin level (HP:0003351) | 3.83732492 |
| 20 | Breech presentation (HP:0001623) | 3.79522954 |
| 21 | Villous atrophy (HP:0011473) | 3.74522271 |
| 22 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.74522271 |
| 23 | Steatorrhea (HP:0002570) | 3.73659216 |
| 24 | Abnormality of carpal bone ossification (HP:0006257) | 3.69522012 |
| 25 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.64820783 |
| 26 | Malnutrition (HP:0004395) | 3.60141600 |
| 27 | Orchitis (HP:0100796) | 3.54887929 |
| 28 | Proximal tubulopathy (HP:0000114) | 3.47923307 |
| 29 | Xanthomatosis (HP:0000991) | 3.47725486 |
| 30 | Spastic paraparesis (HP:0002313) | 3.45255771 |
| 31 | Pustule (HP:0200039) | 3.44246974 |
| 32 | Ureteral stenosis (HP:0000071) | 3.41663136 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36592689 |
| 34 | Hyperactive renin-angiotensin system (HP:0000841) | 3.16077190 |
| 35 | Ureteral obstruction (HP:0006000) | 3.10205171 |
| 36 | Gastrointestinal dysmotility (HP:0002579) | 3.07610247 |
| 37 | Confusion (HP:0001289) | 3.06490046 |
| 38 | Tongue fasciculations (HP:0001308) | 3.05722504 |
| 39 | Sensorimotor neuropathy (HP:0007141) | 3.05010365 |
| 40 | Hyperglycinuria (HP:0003108) | 3.04018269 |
| 41 | Abdominal distention (HP:0003270) | 3.02345250 |
| 42 | Abnormality of renin-angiotensin system (HP:0000847) | 2.97779802 |
| 43 | Alkalosis (HP:0001948) | 2.95443821 |
| 44 | Late onset (HP:0003584) | 2.93464597 |
| 45 | Abnormality of the 2nd finger (HP:0004100) | 2.87737041 |
| 46 | Hypoglycemic coma (HP:0001325) | 2.87630367 |
| 47 | Congenital sensorineural hearing impairment (HP:0008527) | 2.85857480 |
| 48 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.81359012 |
| 49 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.80076920 |
| 50 | Acanthocytosis (HP:0001927) | 2.79905583 |
| 51 | Abnormal ossification of hand bones (HP:0005921) | 2.78435607 |
| 52 | Nausea (HP:0002018) | 2.77336234 |
| 53 | Facial shape deformation (HP:0011334) | 2.74733554 |
| 54 | Potter facies (HP:0002009) | 2.74733554 |
| 55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.73064139 |
| 56 | Short phalanx of the thumb (HP:0009660) | 2.72900670 |
| 57 | Muscle fibrillation (HP:0010546) | 2.72739141 |
| 58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.71891166 |
| 59 | Abnormality of glycine metabolism (HP:0010895) | 2.71891166 |
| 60 | Peritonitis (HP:0002586) | 2.71170166 |
| 61 | Abnormal foot bone ossification (HP:0010675) | 2.69335059 |
| 62 | Hyperuricemia (HP:0002149) | 2.68902167 |
| 63 | Increased purine levels (HP:0004368) | 2.68902167 |
| 64 | Glomerulonephritis (HP:0000099) | 2.68758972 |
| 65 | Petechiae (HP:0000967) | 2.67083365 |
| 66 | Gout (HP:0001997) | 2.65585816 |
| 67 | Abnormal hand bone ossification (HP:0010660) | 2.64647760 |
| 68 | Myositis (HP:0100614) | 2.64223134 |
| 69 | Symptomatic seizures (HP:0011145) | 2.62111098 |
| 70 | Ovoid vertebral bodies (HP:0003300) | 2.61816652 |
| 71 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.61766176 |
| 72 | Hypoglycemic seizures (HP:0002173) | 2.58284868 |
| 73 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.58012254 |
| 74 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.57976584 |
| 75 | Esophageal varix (HP:0002040) | 2.56945316 |
| 76 | Gastrointestinal infarctions (HP:0005244) | 2.55012562 |
| 77 | Ketoacidosis (HP:0001993) | 2.54652897 |
| 78 | Hypothermia (HP:0002045) | 2.50520993 |
| 79 | Hyperammonemia (HP:0001987) | 2.49691452 |
| 80 | Megaloblastic anemia (HP:0001889) | 2.48434170 |
| 81 | Metabolic acidosis (HP:0001942) | 2.48330132 |
| 82 | Hyperphosphatemia (HP:0002905) | 2.48247992 |
| 83 | Metabolic alkalosis (HP:0200114) | 2.46928580 |
| 84 | Intrahepatic cholestasis (HP:0001406) | 2.46521982 |
| 85 | Epidermoid cyst (HP:0200040) | 2.46391071 |
| 86 | Abnormality of magnesium homeostasis (HP:0004921) | 2.45423642 |
| 87 | Cone-rod dystrophy (HP:0000548) | 2.44306326 |
| 88 | Hyperphosphaturia (HP:0003109) | 2.42573309 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 2.42506666 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.42506666 |
| 91 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.41241514 |
| 92 | Overlapping toe (HP:0001845) | 2.40921531 |
| 93 | Abnormality of chloride homeostasis (HP:0011422) | 2.40902032 |
| 94 | Hypotension (HP:0002615) | 2.39216398 |
| 95 | Nephrolithiasis (HP:0000787) | 2.38476769 |
| 96 | Abnormality of purine metabolism (HP:0004352) | 2.38063678 |
| 97 | Hypolipoproteinemia (HP:0010981) | 2.36363233 |
| 98 | Pancreatitis (HP:0001733) | 2.35791818 |
| 99 | Focal segmental glomerulosclerosis (HP:0000097) | 2.35083683 |
| 100 | Hypoalbuminemia (HP:0003073) | 2.33932024 |
| 101 | Abnormal albumin level (HP:0012116) | 2.33932024 |
| 102 | Facial hemangioma (HP:0000329) | 2.32318278 |
| 103 | Alopecia of scalp (HP:0002293) | 2.32259681 |
| 104 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.32188852 |
| 105 | Keratoconjunctivitis sicca (HP:0001097) | 2.31031939 |
| 106 | Hyperglycemia (HP:0003074) | 2.26560995 |
| 107 | Abnormal urine phosphate concentration (HP:0012599) | 2.24833064 |
| 108 | Chronic diarrhea (HP:0002028) | 2.24809355 |
| 109 | Hypophosphatemia (HP:0002148) | 2.23911817 |
| 110 | Tracheal stenosis (HP:0002777) | 2.23835685 |
| 111 | Pigmentary retinal degeneration (HP:0001146) | 2.22844375 |
| 112 | Ketosis (HP:0001946) | 2.21591290 |
| 113 | Pili torti (HP:0003777) | 2.20275912 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 2.18364502 |
| 115 | Woolly hair (HP:0002224) | 2.17976671 |
| 116 | Fat malabsorption (HP:0002630) | 2.17684228 |
| 117 | Dehydration (HP:0001944) | 2.17658033 |
| 118 | Absent phalangeal crease (HP:0006109) | 2.17511180 |
| 119 | Exocrine pancreatic insufficiency (HP:0001738) | 2.14810796 |
| 120 | Complement deficiency (HP:0004431) | 2.13964715 |
| 121 | Keratoconjunctivitis (HP:0001096) | 2.12958309 |
| 122 | Short hallux (HP:0010109) | 2.11082540 |
| 123 | Severe combined immunodeficiency (HP:0004430) | 2.08552165 |
| 124 | Abnormal glucose tolerance (HP:0001952) | 2.07289379 |
| 125 | Posterior subcapsular cataract (HP:0007787) | 2.07286969 |
| 126 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.06896446 |
| 127 | Micronodular cirrhosis (HP:0001413) | 2.06567537 |
| 128 | Biliary tract neoplasm (HP:0100574) | 2.05433354 |
| 129 | Metaphyseal cupping (HP:0003021) | 2.05360211 |
| 130 | Abnormality of nucleobase metabolism (HP:0010932) | 2.04537975 |
| 131 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03991426 |
| 132 | Amyloidosis (HP:0011034) | 2.03958350 |
| 133 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.03712297 |
| 134 | Abnormal biliary tract morphology (HP:0012440) | 2.03177987 |
| 135 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.01745643 |
| 136 | Paraparesis (HP:0002385) | 2.00280311 |
| 137 | Lethargy (HP:0001254) | 1.99908341 |
| 138 | Wide cranial sutures (HP:0010537) | 1.98206723 |
| 139 | Methylmalonic aciduria (HP:0012120) | 1.96892880 |
| 140 | Nephritis (HP:0000123) | 1.96566899 |
| 141 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.94039483 |
| 142 | Irritability (HP:0000737) | 1.91739114 |
| 143 | Cerebral palsy (HP:0100021) | 1.91724133 |
| 144 | Combined immunodeficiency (HP:0005387) | 1.91304799 |
| 145 | Arterial thrombosis (HP:0004420) | 1.91195620 |
| 146 | Widely patent fontanelles and sutures (HP:0004492) | 1.90323087 |
| 147 | Hyperaldosteronism (HP:0000859) | 1.90280639 |
| 148 | Rectal prolapse (HP:0002035) | 1.89900229 |
| 149 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.88670064 |
| 150 | Palpitations (HP:0001962) | 1.88257720 |
| 151 | Cardiovascular calcification (HP:0011915) | 1.87600803 |
| 152 | Eczematoid dermatitis (HP:0000976) | 1.87023272 |
| 153 | Generalized aminoaciduria (HP:0002909) | 1.86236339 |
| 154 | Protuberant abdomen (HP:0001538) | 1.86102835 |
| 155 | Gangrene (HP:0100758) | 1.84900125 |
| 156 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.84176528 |
| 157 | Renal tubular acidosis (HP:0001947) | 1.83344850 |
| 158 | Abnormality of complement system (HP:0005339) | 1.82989696 |
| 159 | Hypokalemia (HP:0002900) | 1.82554248 |
| 160 | Flared iliac wings (HP:0002869) | 1.82348792 |
| 161 | Coxa vara (HP:0002812) | 1.82299694 |
| 162 | Fragile nails (HP:0001808) | 1.81999782 |
| 163 | Vascular calcification (HP:0004934) | 1.80384149 |
| 164 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.80208865 |
| 165 | Abnormality of macular pigmentation (HP:0008002) | 1.80206600 |
| 166 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.80063206 |
| 167 | Autoimmune thrombocytopenia (HP:0001973) | 1.79533237 |
| 168 | Hyperparathyroidism (HP:0000843) | 1.78959954 |
| 169 | Proximal placement of thumb (HP:0009623) | 1.77571886 |
| 170 | Systemic lupus erythematosus (HP:0002725) | 1.75673066 |
| 171 | Abnormal finger flexion creases (HP:0006143) | 1.74557798 |
| 172 | Conjugated hyperbilirubinemia (HP:0002908) | 1.69160079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 6.01670538 |
| 2 | MST1R | 6.00064350 |
| 3 | PIK3CA | 5.27651483 |
| 4 | TBK1 | 5.15213727 |
| 5 | TESK1 | 3.40023998 |
| 6 | KSR2 | 3.18804930 |
| 7 | MAP2K6 | 3.07742845 |
| 8 | MAP2K2 | 2.90258240 |
| 9 | MST4 | 2.85915410 |
| 10 | IKBKE | 2.85823101 |
| 11 | RIPK4 | 2.75223425 |
| 12 | FRK | 2.58909396 |
| 13 | MAP3K2 | 2.52431555 |
| 14 | STK39 | 2.45247629 |
| 15 | LMTK2 | 2.42463693 |
| 16 | GRK6 | 2.28990518 |
| 17 | EPHA3 | 2.21369741 |
| 18 | OXSR1 | 2.19571808 |
| 19 | FGFR4 | 2.02177040 |
| 20 | TAOK2 | 2.01620378 |
| 21 | FGFR3 | 1.98481121 |
| 22 | STK24 | 1.97687751 |
| 23 | TAOK1 | 1.93676235 |
| 24 | PDPK1 | 1.81066653 |
| 25 | GRK1 | 1.75089541 |
| 26 | LIMK1 | 1.74342508 |
| 27 | EPHB2 | 1.72405809 |
| 28 | MET | 1.71941361 |
| 29 | PRKG2 | 1.65849780 |
| 30 | MYLK | 1.58769413 |
| 31 | IKBKB | 1.53600744 |
| 32 | BLK | 1.52930788 |
| 33 | RIPK1 | 1.52880941 |
| 34 | ARAF | 1.48404852 |
| 35 | TLK1 | 1.42570722 |
| 36 | BMPR2 | 1.41471153 |
| 37 | PDK1 | 1.35143434 |
| 38 | PDK2 | 1.33994500 |
| 39 | EPHB1 | 1.33004868 |
| 40 | TNIK | 1.30954778 |
| 41 | IRAK1 | 1.27714034 |
| 42 | MAP3K10 | 1.24882015 |
| 43 | PIM2 | 1.22006971 |
| 44 | FGFR2 | 1.18345048 |
| 45 | MAP3K14 | 1.13504874 |
| 46 | MAP2K1 | 1.13172198 |
| 47 | MAPKAPK3 | 1.12481261 |
| 48 | ERBB4 | 1.11992906 |
| 49 | INSRR | 1.11081888 |
| 50 | MAP3K8 | 1.04927294 |
| 51 | ADRBK2 | 1.03918210 |
| 52 | MAP3K11 | 1.03732549 |
| 53 | MATK | 0.99188911 |
| 54 | DAPK2 | 0.99140961 |
| 55 | NME1 | 0.98451044 |
| 56 | MAP4K2 | 0.97739243 |
| 57 | CAMK2D | 0.97243155 |
| 58 | STK10 | 0.91315113 |
| 59 | RAF1 | 0.89681382 |
| 60 | MELK | 0.89676907 |
| 61 | CASK | 0.88943706 |
| 62 | DMPK | 0.87327582 |
| 63 | STK38L | 0.86046732 |
| 64 | PRKCI | 0.82826341 |
| 65 | MAP3K1 | 0.77629522 |
| 66 | BMX | 0.75235707 |
| 67 | CDC42BPA | 0.72558791 |
| 68 | DDR2 | 0.71086702 |
| 69 | MAP3K12 | 0.70971397 |
| 70 | WNK3 | 0.70493997 |
| 71 | PBK | 0.69392500 |
| 72 | STK3 | 0.68745496 |
| 73 | PIK3CG | 0.68024825 |
| 74 | TTK | 0.62740596 |
| 75 | EPHA2 | 0.62470157 |
| 76 | PRKCZ | 0.61706934 |
| 77 | PTK6 | 0.57089848 |
| 78 | PRKCE | 0.56059844 |
| 79 | MAPK11 | 0.54070156 |
| 80 | BMPR1B | 0.53825206 |
| 81 | MAP3K3 | 0.52662164 |
| 82 | HIPK2 | 0.52081236 |
| 83 | YES1 | 0.50720428 |
| 84 | ABL2 | 0.50043787 |
| 85 | JAK1 | 0.48919473 |
| 86 | BRAF | 0.48778905 |
| 87 | NUAK1 | 0.48716013 |
| 88 | MARK3 | 0.48101353 |
| 89 | TESK2 | 0.47559907 |
| 90 | TAOK3 | 0.47175248 |
| 91 | NLK | 0.46571757 |
| 92 | AKT3 | 0.46340629 |
| 93 | MAP3K5 | 0.44785772 |
| 94 | EPHA4 | 0.42238087 |
| 95 | PKN1 | 0.42062353 |
| 96 | STK11 | 0.42011212 |
| 97 | PRKCA | 0.41578413 |
| 98 | PTK2 | 0.41064122 |
| 99 | PIM1 | 0.39999953 |
| 100 | ERBB2 | 0.37796566 |
| 101 | ERBB3 | 0.37197009 |
| 102 | MAP4K1 | 0.36635411 |
| 103 | CAMK2G | 0.36493678 |
| 104 | PRKAA1 | 0.36464659 |
| 105 | CSK | 0.35787494 |
| 106 | CSNK1A1 | 0.35087985 |
| 107 | MAP2K3 | 0.34610503 |
| 108 | SRC | 0.34404631 |
| 109 | JAK2 | 0.34188061 |
| 110 | DAPK3 | 0.32849544 |
| 111 | TXK | 0.32792223 |
| 112 | PINK1 | 0.32531762 |
| 113 | PRKAA2 | 0.30537158 |
| 114 | GSK3A | 0.29442570 |
| 115 | CAMK2B | 0.27400816 |
| 116 | LYN | 0.27276757 |
| 117 | PRKACA | 0.27239724 |
| 118 | PRKCD | 0.26195336 |
| 119 | PAK3 | 0.25698748 |
| 120 | PDK3 | 0.24840095 |
| 121 | PDK4 | 0.24840095 |
| 122 | FYN | 0.24407468 |
| 123 | ITK | 0.23028578 |
| 124 | IGF1R | 0.21267465 |
| 125 | DAPK1 | 0.21231376 |
| 126 | KSR1 | 0.21116918 |
| 127 | ERN1 | 0.20252640 |
| 128 | PRKG1 | 0.19301450 |
| 129 | PRKD1 | 0.19291575 |
| 130 | NEK6 | 0.19235163 |
| 131 | CDK9 | 0.19221927 |
| 132 | MAP3K9 | 0.18887794 |
| 133 | PHKG1 | 0.18820839 |
| 134 | PHKG2 | 0.18820839 |
| 135 | PRKACG | 0.18505825 |
| 136 | PRKCQ | 0.18123404 |
| 137 | FER | 0.17929028 |
| 138 | PRKCB | 0.17343503 |
| 139 | MAPKAPK2 | 0.17342836 |
| 140 | PAK1 | 0.17193865 |
| 141 | TYK2 | 0.16752816 |
| 142 | MAP3K7 | 0.16555519 |
| 143 | CSNK1G1 | 0.16540157 |
| 144 | ZAP70 | 0.16449109 |
| 145 | PRKACB | 0.15901876 |
| 146 | MAPK4 | 0.15683455 |
| 147 | WNK4 | 0.15381212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 5.90253278 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.85778215 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.16287499 |
| 4 | Mineral absorption_Homo sapiens_hsa04978 | 4.07380025 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.78397341 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.34495707 |
| 7 | Bile secretion_Homo sapiens_hsa04976 | 2.37514199 |
| 8 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.19814831 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.87369421 |
| 10 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.82522033 |
| 11 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.80517414 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.78980023 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 1.78235544 |
| 14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.72532966 |
| 15 | Galactose metabolism_Homo sapiens_hsa00052 | 1.70200402 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.67364178 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61198321 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49679552 |
| 19 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.43001967 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.37196246 |
| 21 | Pertussis_Homo sapiens_hsa05133 | 1.32681931 |
| 22 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26953967 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26626640 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.23095883 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21741341 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.21602872 |
| 27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18696382 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.17743702 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17170814 |
| 30 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.16681349 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.13640958 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13098875 |
| 33 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.11628910 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07750370 |
| 35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.07181777 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02461344 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01914918 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99821270 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98661570 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 0.96649000 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 0.94838968 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93739829 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.88599037 |
| 44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88074298 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.88073663 |
| 46 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87222866 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85729247 |
| 48 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.84911492 |
| 49 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83136525 |
| 50 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82360098 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82294593 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.80042041 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76809205 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.76193737 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75370030 |
| 56 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75271758 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73355109 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72564926 |
| 59 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71350039 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.70732054 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70434706 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 0.69635139 |
| 63 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68962015 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68932411 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66941109 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66013327 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.65531565 |
| 68 | Insulin secretion_Homo sapiens_hsa04911 | 0.64594152 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61929766 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61662987 |
| 71 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.61372226 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59562780 |
| 73 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58570242 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58321279 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.58227096 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.57946234 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57673151 |
| 78 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55963768 |
| 79 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52605467 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51752707 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.51550646 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.51476921 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50722055 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50288428 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49304802 |
| 86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49076181 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.47253698 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.44971976 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44052533 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.42483574 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41651388 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40971253 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38889690 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38293176 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38085161 |
| 96 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37248984 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36807557 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36522270 |
| 99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36122791 |
| 100 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.35583722 |
| 101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33471869 |
| 102 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.32917014 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.32857758 |
| 104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.32019569 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28688077 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27800685 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.27725755 |
| 108 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.27409123 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.26889080 |
| 110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26164426 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.24883943 |
| 112 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.24381574 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.23622580 |
| 114 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22486526 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.21307604 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.21265054 |
| 117 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.20989451 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20287526 |
| 119 | Adherens junction_Homo sapiens_hsa04520 | 0.19194539 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18771666 |
| 121 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.16512588 |
| 122 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.15649026 |
| 123 | Parkinsons disease_Homo sapiens_hsa05012 | 0.15355995 |
| 124 | Cocaine addiction_Homo sapiens_hsa05030 | 0.15170293 |
| 125 | Apoptosis_Homo sapiens_hsa04210 | 0.15032347 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.14660585 |
| 127 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.14238433 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14031470 |
| 129 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.10661417 |
| 130 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.09063242 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.08496953 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08415027 |
| 133 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.08128461 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.08117080 |
| 135 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.07443483 |
| 136 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.06465891 |

